Alexey Matveev

Title: Alexey Matveev: Innovator in Pharmaceutical Chemistry

Introduction

Alexey Matveev is a notable inventor based in Kharkiv, Ukraine. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of anthracyclin compounds. With a total of 3 patents to his name, Matveev's work has the potential to impact cancer treatment methodologies.

Latest Patents

One of Matveev's latest patents is a method for preparing 4-demethyldaunorubicin. This innovative method involves reacting daunorubicin or N-protected daunorubicin with soft Lewis acids to demethylate the 4-methoxy group. The resulting reaction mass is treated with an aqueous solution of a strong organic acid or a mineral acid, leading to the extraction of carminomycin as a base.

Another significant patent is the synthesis of epirubicin from 13-dihydrodaunorubicine. This method outlines a multi-step process that begins with the production of N-Trifluoroacetyl-13-daunorubicinol from 13-daunorubicinol through acylation. The subsequent reactions involve various agents and conditions to ultimately yield the desired compound, N-Trifluoroacetyl-4′-epi-daunorubicin.

Career Highlights

Matveev is currently employed at Solux Corporation, where he continues to advance his research in pharmaceutical innovations. His work is characterized by a focus on improving the efficacy and safety of cancer treatment drugs.

Collaborations

Throughout his career, Matveev has collaborated with esteemed colleagues, including Alexander F Zabudkin and Victor Matvienko. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Alexey Matveev's contributions to pharmaceutical chemistry, particularly in the development of anthracyclin compounds, highlight his role as an influential inventor. His innovative methods and collaborative efforts continue to pave the way for advancements in cancer treatment.